EGLN2 and cancer: Besides its function as inhibitor of HIF1α stability, PHD1 has either tumor promoting or suppressing activity depending on the cell and cancer type-specific signaling pathways (Jokilehto and Jaakkola 2010; Seth et al. 2002; Erez et al. 2003).